Learn what works and then try to apply it to your marketplace, explained Tesh Khullar, senior vice president and advisor, Flatiron Health.
Learn what works and then try to apply it to your marketplace, explained Tesh Khullar, senior vice president & advisor, Flatiron Health
Transcript
What are some best practices trying to keep up with practice transformation under value-based care?
I think learning and coming to meetings and learning what other practices are doing. We’re at the cutting edge of value-based care. You have groups like [South Carolina Oncology Associates] in South Carolina that are doing custom deals with their payers in their marketplace. Learning what’s working for other practices and then incorporating that and having a conversation with your payer about being the lower cost provider and what you can do to help the payer lower cost, which ultimately is going to lower cost for the patients, is what practices have to do. So, learn what works and then try to apply it to your marketplace, in particular.
The Challenge of Addressing Drug Spend to Drive Down Total Cost of Care in EOM
October 27th 2024Stuart Staggs, vice president of transformation and shared services at McKesson, explained that oncology practices in the Enhancing Oncology Model (EOM) have a tough job driving down costs when drug costs make up a larger portion of the total cost of care.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Targeting Progression: Amivantamab’s Role in NSCLC After Osimertinib
October 24th 2024Amivantamab's role in non–small cell lung cancer (NSCLC) has been a highlight of the lung cancer space this year, with the 2 most recent approvals based on data from the MARIPOSA and MARIPOSA-2 trials.
Read More
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More